The pharmaceutical industry is aggressively evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To https://tirzepatides.us/oligonucleotide